- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02295800
The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV
January 2, 2018 updated by: Elizabeth Glaser Pediatric AIDS Foundation
The study design includes an observational prospective cohort of HIV-positive pregnant/postpartum women and their infants enrolled during antenatal clinics (or immediately postpartum) from prevention of mother-to-child transmission (PMTCT) programs and followed until the infants reach the age of 18 - 24 months and semi-structure interviews with a sub-set of these women.
A second study component involves semi-structured interviews with health care workers (HCW) involved in the PMTCT programs and yearly facility surveys at the selected study facilities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1216
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kigali, Rwanda, BP 2788
- Elizabeth Glaser Pediatric AIDS Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant women identified as HIV infected during antenatal care and receiving PMTCT services (regardless of ARV regimen received) in the selected antenatal clinics in Kigali, Rwanda are eligible for study enrollment.
The infants born to enrolled study women during the study pregnancy will also be study participants up to the age of 18 - 24 months.
Description
Inclusion Criteria:
- Documented HIV infection
- Pregnant, in the last trimester of pregnancy or within two weeks post-delivery.
- Participation in the PMTCT program during antenatal care at one of the study sites
- Planning on remaining in the Kigali area after delivery
- Able and willing to give informed consent for study participation for herself and her infant(s).
If a pregnant woman is less than 18 years of age and still living with her parents, informed consent will also be required from one of her parents
Exclusion Criteria:
- Women not willing to provide informed consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Mothers
HIV Infected mothers
|
|
Infants
HIV exposed infants
|
|
Healthcare workers
Facility based healthcare workers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
18 - 24 month HIV-free survival of children born to HIV-positive pregnant women
Time Frame: 18 - 24 months
|
18 - 24 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HIV-exposed infants with stunting, underweight, or wasting Infants and young children breastfed (exclusive or any breastfeeding) at various ages
Time Frame: 18 - 24 months
|
18 - 24 months
|
Infants and young children breastfed (exclusive or any breastfeeding) at various ages
Time Frame: 18 - 24 months
|
18 - 24 months
|
Adherence to the universal antiretroviral therapy (ARV) regimen among pregnant and postpartum women (Option B+) and their HIV-exposed children, including the proportion of study women with HIV RNA < 1000 copies/ml or > 2 log10 copies/mL decrease in viral
Time Frame: 18 - 24 months
|
18 - 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Emily A. Bobrow, PhD, MPH, Elizabeth Glaser Pediatric AIDS Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2013
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
October 15, 2014
First Submitted That Met QC Criteria
November 17, 2014
First Posted (Estimate)
November 20, 2014
Study Record Updates
Last Update Posted (Actual)
January 4, 2018
Last Update Submitted That Met QC Criteria
January 2, 2018
Last Verified
November 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EGPAF0098
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mother-to-child HIV Transmission
-
ANRS, Emerging Infectious DiseasesNot yet recruitingMother to Child HIV Transmission
-
French National Agency for Research on AIDS and...RecruitingMother to Child Transmission of HIVFrance
-
Harvard School of Public Health (HSPH)Elton John AIDS Foundation; Management and Development for Health, Tanzania; Comic...CompletedPregnancy | Mother-to-child Transmission of HIVTanzania
-
Chinese University of Hong KongRecruitingGut Microbiome | Mother to Child TransmissionChina
-
ANRS, Emerging Infectious DiseasesCompletedMother to Child HIV TransmissionGuinea
-
University of ZimbabweNORHEDCompletedPrevention of Mother-to-child Transmission of HIVZimbabwe
-
Pacific Institute for Research and EvaluationFogarty International Center of the National Institute of Health; Kenya Medical... and other collaboratorsActive, not recruitingHIV | Pregnancy in Adolescence | Social Stigma | Mother to Child Transmission | Self DisclosureKenya
-
University of KwaZuluUniversity of California, San Francisco; Centers for Disease Control and Prevention and other collaboratorsCompletedEffectiveness of an HIV-adapted IMCI Training and Supervision Programme for Community Health WorkersInfant Feeding Practices | Prevention of Mother-to-child Transmission of HIV | Antenatal Health Care Utilization | Postnatal Health Care UtilizationSouth Africa
-
ANRS, Emerging Infectious DiseasesRecruitingMother to Child Transmission of HIVFrance, French Guiana, Guadeloupe, Martinique
-
Radboud University Medical CenterCompletedPregnancy | HIV-infection | Mother to Child TransmissionZambia, Tanzania
Clinical Trials on Standard of care
-
brett rasmussenCompleted
-
Johns Hopkins UniversityRecruitingCompartment Syndrome of Leg | Extracorporeal Membrane Oxygenation Complication | Limb Ischemia, Critical | Limb IschemiaUnited States
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted